Mr Mohammad Ismail
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
I'm a PhD candidate in the Prostate Cancer Research Group at SAHMRI, under the supervision of Dr. Zeyad Nassar and led by Professor Lisa Butler. My research centers on investigating the genetic landscape of prostate cancer, specifically targeting key metabolic pathways in prostate cancer. I'm deeply passionate about this endeavor and excited to contribute to our team's mission.
| Date | Position | Institution name |
|---|---|---|
| 2019 - 2022 | Research Assisstant | Cell Therapy Center, Amman |
| 2017 - 2018 | Medical Laboratory Technician | AL-Istiashari Hospita; |
| Language | Competency |
|---|---|
| Arabic | Can read, write, speak and understand spoken |
| English | Can read, write, speak and understand spoken |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2018 - 2021 | The University of Jordan | Jordan | Masters Degree |
| 2013 - 2017 | Hashemite University | Jordan | Bachelors Drgree |
| Year | Citation |
|---|---|
| 2026 | Ababneh, N. A., Gharandouq, M. H., Ismail, M. A., AlDiqs, R., Hamdan, O., Musa, Q., . . . Saleh, T. (2026). Niacin Protects iPSC-Derived Neurons from Chemotherapy-Induced Toxicity. Neurotoxicity Research, 44(2), 15 pages. Scopus2 WoS2 Europe PMC2 |
| 2026 | Abuhammad, A., Sabri, T., Ababneh, N. A., Ali, R. A., Ismail, M. A., Madadha, A., . . . Sim, E. (2026). Fragment-Derived Nicotinic Acid Analogues Inhibit hCA III and Downregulate CA3 Expression in HepG2 Cells. Biomolecules, 16(4), 20 pages. |
| 2025 | Hussein, S. A., Ababneh, N. A., Tarawneh, N., Ismail, M. A., Awidi, A., & Abdalla, S. (2025). Antitumor Effects of Quercetin and Luteolin in A375 Cutaneous Melanoma Cell Line Are Mediated by Upregulation of P-ERK, c-Myc, and the Upstream GPER. Life, 15(3), 21 pages. Scopus10 WoS10 Europe PMC9 |
| 2025 | Gharandouq, M. H., Ismail, M. A., Saleh, T., Zihlif, M., & Ababneh, N. A. (2025). Metformin Protects Human Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons from Oxidative Damage Through Antioxidant Mechanisms. Neurotoxicity Research, 43(2), 17 pages. Scopus3 WoS3 Europe PMC2 |
| 2025 | Aldiqs, R., Nashwan, S., Ismail, M. A., Saleh, T., Barham, R., Zihlif, M., & Ababneh, N. A. (2025). Effect of exosomes derived from induced and human adipose tissue-derived mesenchymal stem cells on human cancer cells. Journal of Biosciences, 50(2), 15 pages. Scopus2 WoS2 Europe PMC2 |
| 2025 | Nashwan, S., Ismail, M. A., Saleh, T., Hadidi, S. A., Alwohoush, E., Sarhan, M., . . . Ababneh, N. A. (2025). Comparative analysis of extracellular vesicles from induced and adipose-derived Mesenchymal Stem Cells: Implications for regenerative medicine. Plos One, 20(6 June), 16 pages. Scopus5 WoS5 Europe PMC5 |
| 2025 | Ababneh, N. A., AlDiqs, R., Nashwan, S., Ismail, M. A., Barham, R., Alatoom, R. M., . . . Saleh, T. (2025). Exosomes Derived from Induced and Wharton’s Jelly-Derived Mesenchymal Stem Cells Promote Senescence-like Features and Migration in Cancer Cells. International Journal of Molecular Sciences, 26(13), 18 pages. Scopus9 WoS4 |
| 2025 | Ababneh, N. A., AlDiqs, R., Nashwan, S., Ismail, M. A., Barham, R., Nairat, F., . . . Awidi, A. (2025). hPL-conditioned MSC-derived extracellular vesicles exhibit enhanced anticancer effects on MCF7 and A549 cells. Future Science Oa, 11(1), 16 pages. |
| 2025 | Ababneh, N. A., AlDiqs, R., Gharandouq, M. H., Ismail, M. A., Barham, R., Nairat, F., . . . Saleh, T. (2025). Coenzyme Q10 Ameliorates Chemotherapy-Induced Neurotoxicity in iPSC-Derived Neurons by Reducing Oxidative Stress. International Journal of Molecular Sciences, 26(19), 14 pages. Scopus4 WoS3 Europe PMC2 |
| 2025 | Ababneh, N. A., Nashwan, S., AlDiqs, R., Ismail, M. A., Abdulelah, A. A., Abu-Humaidan, A. H. A., . . . Awidi, A. (2025). Cancer cell-dependent increase in senescence-like populations following exosome treatment from bone marrow and induced pluripotent stem cell-derived mesenchymal stem cells. World Journal of Stem Cells, 17(11), 1-20. Scopus3 WoS3 Europe PMC1 |
| 2025 | Ababneh, N. A., Alwohoush, E., AlDiqs, R., Ismail, M. A., Al-Kurdi, B., Barham, R., . . . Awidi, A. (2025). Impact of differentiation protocols on the functionality of mesenchymal stem cells derived from induced pluripotent stem cells. World Journal of Stem Cells, 17(12), 1-17. Scopus4 WoS4 Europe PMC2 |
| 2025 | Abdo, E., Ismail, M. A., Al Hadidi, S., Al-Mrahleh, M., Saleh, T., Zihlif, M., & Ababneh, N. A. (2025). Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells.. PloS one, 20(1), e0311615. Europe PMC3 |
| 2025 | Ababneh, N. A., Aldiqs, R., Nashwan, S., Ismail, M. A., Barham, R., Al Hadidi, S., . . . Awidi, A. (2025). Distinct anticancer properties of exosomes from induced mesenchymal stem cells vs. bone marrow-derived stem cells in MCF7 and A549 models.. Biomedical reports, 23(1), 116. Europe PMC5 |
| 2024 | Al-Asmar, A. A., Abuarqoub, D., Ababneh, N., Jafar, H., Zalloum, S., Ismail, M., . . . Awidi, A. (2024). Potential Effects of Photobiomodulation Therapy on Human Dental Pulp Stem Cells. APPLIED SCIENCES-BASEL, 14(1), 14 pages. WoS5 |
| 2024 | Abu-Humaidan, A. H. A., Ismail, M. A., Ahmad, F. M., Al Shboul, S., Barham, R., Tadros, J. S., . . . Saleh, T. (2024). Therapy-induced senescent cancer cells exhibit complement activation and increased complement regulatory protein expression. Immunology and Cell Biology, 102(4), 240-255. Scopus9 WoS10 Europe PMC10 |
| 2024 | Saleh, T., Naffa, R., Barakat, N. A., Ismail, M. A., Alotaibi, M. R., & Alsalem, M. (2024). Cisplatin Provokes Peripheral Nociception and Neuronal Features of Therapy-Induced Senescence and Calcium Dysregulation in Rats. Neurotoxicity Research, 42(1), 15 pages. Scopus8 WoS8 Europe PMC8 |
| 2024 | Alwohoush, E., Ismail, M. A., Al-Kurdi, B., Barham, R., Al Hadidi, S., Awidi, A., & Ababneh, N. A. (2024). Effect of hypoxia on proliferation and differentiation of induced pluripotent stem cell-derived mesenchymal stem cells.. Heliyon, 10(19), e38857. Europe PMC10 |
| 2023 | Alrabayah, M., Massad, I. M., Imraish, A., Jarrar, Y., Massad, F., Guzu, H., . . . Zihlif, M. (2023). Effects of <i>CYP2B6</i> Genetic Variants on the Propofol Dose and Response among Jordanian Arabic Patients Undergoing General Anesthesia. CURRENT DRUG METABOLISM, 23(14), 1156-1161. WoS2 Europe PMC2 |
| 2023 | El-Sadoni, M., Al Shboul, S., Alhesa, A., Shahin, N. A., Alsharaiah, E., Ismail, M. A., . . . Saleh, T. (2023). A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 91(4), 345-360. WoS20 Europe PMC23 |
| 2023 | Asad, M. M., Abdelhafez, R. S., Barham, R., Abdaljaleel, M., Alkurdi, B., Al-Hadidi, S., . . . Ababneh, N. A. (2023). Three-dimensional cultures of gingival fibroblasts on fibrin-based scaffolds for gingival augmentation: A proof-of-concept study. ARCHIVES OF ORAL BIOLOGY, 154, 8 pages. WoS4 Europe PMC1 |
| 2023 | Abu-Humaidan, A., Ismail, M. A., Barham, R., Ahmad, F. M., Ababneh, N. A., & Saleh, T. (2023). Therapy induced senescence in cancer cell lines affects complement activation and complement regulatory proteins expression. IMMUNOBIOLOGY, 228(5), 93. |
| 2023 | Al Shboul, S., El-Sadoni, M., Alhesa, A., Abu Shahin, N., Abuquteish, D., Abu Al Karsaneh, O., . . . Saleh, T. (2023). NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy. Scientific Reports, 13(1), 1-12. WoS19 Europe PMC18 |
| 2023 | Niemi, M. E. K., Karjalainen, J., Liao, R. G., Neale, B. M., Daly, M., Ganna, A., . . . Sedaghati-Khayat, B. (2023). Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x). Nature, 621(7977), E7-E26. Scopus92 WoS104 Europe PMC101 |
| 2022 | Ababneh, N. A., Barham, R., Al-Kurdi, B., Ali, D., Al Hadidi, S., Ismail, M. A., . . . Awidi, A. (2022). Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p. Arg707Trp) in MFN2 gene. STEM CELL RESEARCH, 62, 5 pages. WoS3 Europe PMC4 |
| 2021 | Sweidan, N., Esawi, E., Ismail, M., & Alshaer, W. (2021). Anticancer Cardenolides from the aerial parts of Calortopis procera. Zeitschrift Fur Naturforschung Section C Journal of Biosciences, 76(5), 243-250. Scopus5 WoS5 Europe PMC3 |
| 2020 | Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., . . . Ismail, S. I. (2020). Aptamers chemistry: Chemical modifications and conjugation strategies. Molecules, 25(1), 51 pages. Scopus364 WoS326 Europe PMC249 |
| Year | Citation |
|---|---|
| 2022 | Nsairat, H., Alshaer, W., Mahmoud, I. S., Ismail, M. A., Esawi, E., Alsotari, S., & Ismail, S. I. (2022). Aptamers in Theranostic Bionanomaterials. In Bionanotechnology Next Generation Therapeutic Tools (pp. 130-158). BENTHAM SCIENCE PUBLISHERS. DOI Scopus1 |
| Year | Citation |
|---|---|
| 2025 | Hussein, S. A., Ababneh, N. A., Tarawneh, N., Ismail, M. A., Awidi, A., & Abdalla, S. (2025). Antitumor Effects of Quercetin and Luteolin Are Mediated by Up-Regulation of P-Erk, C-Myc, and the Upstream Gper in A375 Melanoma Cell Line. DOI |
Connect With Me
External Profiles
